Disc Medicine (IRON) Shares Outstanding (Diluted Average) (2021 - 2026)

Disc Medicine (IRON) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $38.5 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $38.5 million, up 15.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.5 million (up 15.5% YoY), and the FY2025 annual result was $35.3 million, up 27.85% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $38.5 million in Q1 2026 per IRON's latest filing, from $35.3 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $38.5 million in Q1 2026 and troughed at $204081.0 in Q2 2023.
• A 5-year average of $20.7 million and a median of $24.8 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) tumbled 97.83% in 2022, then surged 12468.07% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.0 million in 2022, then jumped by 2046.81% to $22.3 million in 2023, then grew by 23.71% to $27.6 million in 2024, then rose by 27.85% to $35.3 million in 2025, then climbed by 9.05% to $38.5 million in 2026.
• Business Quant data shows IRON's Shares Outstanding (Diluted Average) at $38.5 million in Q1 2026, $35.3 million in Q4 2025, and $35.2 million in Q3 2025.